0000000000292799
AUTHOR
Joel T. Mague
2-({5-[(4-Chlorophenoxy)methyl]-4-phenyl-4H-1,2,4-triazol-3-yl}sulfanyl)-N-phenylacetamide
The title molecule, C23H19ClN4O2S, is in an `extended' conformation. In the crystal, pairwise N—H...N and C—H...O hydrogen bonds lead to the formation of `stair-step' chains. C—H...π interactions further contribute to the consolidation of the molecular packing. The 4-chlorophenyl group is disordered over two sets of sites in a 0.948 (2):0.052 (2) ratio. The dihedral angle between the two components of the disordered chloro-substituted benzene ring is 15.76 (9) °.
2-(3-Methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)acetic acid dihydrate
In the title compound, C11H10N2O3·2H2O, the constituent atoms of the dihydroquinoxaline moiety deviate from the mean plane of the unit by +0.0572 (8) to −0.0874 (8) Å while the acetic acid substituent is nearly orthogonal to this plane. The crystal packing consists of corrugated layers constructed by O—H...O, O—H...N and C—H...O hydrogen bonds, which also involve the lattice water molecules. O—H...O hydrogen bonds and π–π stacking interactions hold these layers together.